Generics, Contract Manufacturing
Total Trials
36
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,531
NCT00596063
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2008
Completion: Feb 29, 2008
NCT00719108
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
Start: Jul 31, 2008
Completion: Sep 30, 2008
NCT00752180
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
Start: Aug 31, 2008
Completion: Apr 30, 2009
NCT00772265
Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects
Start: Sep 30, 2010
Completion: Apr 30, 2011
NCT01358435
Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects
Start: Jan 31, 2011
Completion: May 31, 2011
NCT04874324
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349
Start: Mar 17, 2011
Completion: Jun 25, 2011
NCT01308437
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Phase: Phase 3
Start: Mar 31, 2011
Completion: Apr 30, 2013
NCT01357603
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM
Start: Jun 30, 2011
Completion: Aug 31, 2012
NCT01399255
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects
Start: Nov 30, 2011
Completion: Jun 30, 2012
NCT01400802
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects
NCT05640531
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771
Start: Dec 1, 2011
Completion: Jun 27, 2012
NCT01398670
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
Start: Feb 29, 2012
Completion: May 31, 2013
NCT03926962
The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers
Start: Mar 14, 2013
Completion: Jul 13, 2013
NCT01875939
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
Start: Jun 30, 2013
Completion: Jun 30, 2013
NCT03979859
Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers
Start: Aug 20, 2013
Completion: Dec 30, 2013
NCT02217930
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
Start: Aug 31, 2014
Completion: Jul 31, 2015
NCT02244827
Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment
Start: Sep 30, 2014
Completion: Jun 30, 2015
NCT02253342
Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects
Completion: Aug 31, 2015
NCT02453529
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Start: Apr 30, 2015
NCT02532140
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
Start: Aug 31, 2015
Completion: Dec 31, 2015
NCT02674347
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
Start: Feb 29, 2016
Completion: Apr 30, 2016
NCT02707107
MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers
Start: Mar 31, 2016
NCT02709382
A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment
Completion: Aug 31, 2016
NCT02770404
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
Start: Apr 25, 2016
Completion: Dec 25, 2016
NCT02942810
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment
Start: Oct 25, 2016
Completion: Apr 30, 2017
NCT02903836
Phase II Study of Oral Nafithromycin in CABP
Phase: Phase 2
Start: Nov 18, 2016
Completion: Jul 8, 2017
NCT03554304
Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
Start: Feb 9, 2017
Completion: Oct 6, 2017
NCT03630094
Plasma and Intrapulmonary Concentrations Study of WCK 5222
Start: Mar 31, 2017
Completion: Jul 30, 2017
NCT03405064
Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Start: Aug 25, 2017
Completion: Nov 30, 2018
NCT03622008
To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)
Start: Mar 23, 2018
Completion: May 30, 2018
NCT03981887
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin
Start: Jun 18, 2019
Completion: Aug 7, 2019
NCT04979806
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Start: Aug 28, 2022
Completion: Nov 25, 2024
NCT03630081
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Start: Jan 31, 2024
Completion: Feb 28, 2026
NCT06806995
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
Start: Jan 21, 2025
Completion: Feb 17, 2025
Loading map...